This review offers a framework for Medicaid programs to broadly assess cell and gene therapies, evaluate payment options, and ensure equitable access. Share: Previous Post Systemic Corticosteroids to Prevent Bronchopulmonary Dysplasia Next Post JAMA Pediatrics Related Articles Clinical Practice Guidelines What Parents Should Know About Returning to Work While Breastfeeding Clinical Practice Guidelines Inhaled Corticosteroids Alone and With Long-Acting β 2 Receptor Agonists in Preterm-Born Children Clinical Practice Guidelines Error in Figures Clinical Practice Guidelines Modeling Cost and Outcomes of SARS-CoV-2 School Testing Programs—Reply Clinical Practice Guidelines Medical Practice (Updated 15 min) Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment Name * Email * Website Save my name, email, and website in this browser for the next time I comment.